Как стать счастливее и уверенно идти к своим целям? Все ответы — в книге «Сам себе государство. Как совершить революцию в жизни». Купить ‎«Behind the Money»: «Moderna’s race to the vaccine» в Apple Podcasts

19 мин.

Moderna’s race to the vaccine Behind the Money

    • Деловые новости

The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one of the first to bring a Covid-19 vaccine to market. Hannah Kuchler, the FT’s US pharma and biotech correspondent, reports on Moderna’s race to find an immunisation for the novel coronavirus.  


The FT is making key coronavirus coverage free to read for everyone. Go to ft.com/coronavirusfree to read the latest.


Read more here: Moderna’s Covid vaccine offers vindication of its unconventional approach


Review clips: Yahoo Finance, CNBC
 
See acast.com/privacy for privacy and opt-out information.

The Boston-based biotech eschewed a traditional approach to vaccine development, instead pitching its use of mRNA technology to investors. That pitch paid off this year as the company stands to be one of the first to bring a Covid-19 vaccine to market. Hannah Kuchler, the FT’s US pharma and biotech correspondent, reports on Moderna’s race to find an immunisation for the novel coronavirus.  


The FT is making key coronavirus coverage free to read for everyone. Go to ft.com/coronavirusfree to read the latest.


Read more here: Moderna’s Covid vaccine offers vindication of its unconventional approach


Review clips: Yahoo Finance, CNBC
 
See acast.com/privacy for privacy and opt-out information.

19 мин.

Еще от: Financial Times